News
Hims & Hers Health (NYSE:HIMS) plans to offer $450M aggregate principal amount of convertible senior notes due 2030 in a private offering. The notes will accrue interest payable semi-annually in ...
Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Hims & Hers reports 111% YoY sales growth & 70%+ gross margin. Discover their growth potential, risks, & why it's a Buy ...
Nader Kabbani, who led the technology giant’s acquisition of PillPack and the launch of Amazon Pharmacy, will take the chief ...
We recently published a list of Here’s What Fueled These 10 Firms’ Surge. In this article, we are going to take a look at ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback